vs
Axogen, Inc.（AXGN）与Ceribell, Inc.（CBLL）财务数据对比。点击上方公司名可切换其他公司
Axogen, Inc.的季度营收约是Ceribell, Inc.的2.4倍（$59.9M vs $24.8M）。Axogen, Inc.净利率更高（-22.0% vs -54.6%，领先32.6%）。Axogen, Inc.自由现金流更多（$1.8M vs $-11.0M）
Axogen总部位于美国佛罗里达州阿拉楚阿，是外科解决方案提供商，专注开发周围神经损伤修复相关产品，涵盖人体组织移植物、神经连接器、软组织膜等，旗下AVANCE细胞移植技术可模拟人体神经结构，临床数据显示其产品帮助87%的周围神经损伤患者实现感觉与运动功能恢复，2013年完成1800万美元首次公开募股。
Ceribell, Inc.是一家专注于神经诊断领域的医疗科技企业，主打便携式快速脑电图检测设备，可为急症、重症护理场景提供便捷的癫痫发作监测解决方案，核心市场覆盖北美地区，目前正逐步推进全球化业务布局。
AXGN vs CBLL — 直观对比
营收规模更大
AXGN
是对方的2.4倍
$24.8M
净利率更高
AXGN
高出32.6%
-54.6%
自由现金流更多
AXGN
多$12.7M
$-11.0M
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $59.9M | $24.8M |
| 净利润 | $-13.2M | $-13.5M |
| 毛利率 | 74.1% | 87.3% |
| 营业利润率 | -16.3% | -58.9% |
| 净利率 | -22.0% | -54.6% |
| 营收同比 | 21.3% | — |
| 净利润同比 | -3023.6% | — |
| 每股收益（稀释后） | $-0.28 | $-0.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXGNCBLL
| Q4 25 | $59.9M | $24.8M | ||
| Q3 25 | $60.1M | $22.6M | ||
| Q2 25 | $56.7M | $21.2M | ||
| Q1 25 | $48.6M | $20.5M | ||
| Q4 24 | $49.4M | — | ||
| Q3 24 | $48.6M | $17.2M | ||
| Q2 24 | $47.9M | — | ||
| Q1 24 | $41.4M | — |
净利润AXGNCBLL
| Q4 25 | $-13.2M | $-13.5M | ||
| Q3 25 | $708.0K | $-13.5M | ||
| Q2 25 | $579.0K | $-13.6M | ||
| Q1 25 | $-3.8M | $-12.8M | ||
| Q4 24 | $450.0K | — | ||
| Q3 24 | $-1.9M | $-10.4M | ||
| Q2 24 | $-1.9M | — | ||
| Q1 24 | $-6.6M | — |
毛利率AXGNCBLL
| Q4 25 | 74.1% | 87.3% | ||
| Q3 25 | 76.6% | 88.3% | ||
| Q2 25 | 74.2% | 88.1% | ||
| Q1 25 | 71.9% | 87.9% | ||
| Q4 24 | 76.1% | — | ||
| Q3 24 | 74.9% | 87.3% | ||
| Q2 24 | 73.8% | — | ||
| Q1 24 | 78.8% | — |
营业利润率AXGNCBLL
| Q4 25 | -16.3% | -58.9% | ||
| Q3 25 | 3.2% | -64.8% | ||
| Q2 25 | 3.0% | -70.5% | ||
| Q1 25 | -3.4% | -69.3% | ||
| Q4 24 | 4.1% | — | ||
| Q3 24 | -0.6% | -57.8% | ||
| Q2 24 | -0.9% | — | ||
| Q1 24 | -11.0% | — |
净利率AXGNCBLL
| Q4 25 | -22.0% | -54.6% | ||
| Q3 25 | 1.2% | -59.6% | ||
| Q2 25 | 1.0% | -64.4% | ||
| Q1 25 | -7.9% | -62.4% | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | -3.8% | -60.6% | ||
| Q2 24 | -4.0% | — | ||
| Q1 24 | -16.0% | — |
每股收益（稀释后）AXGNCBLL
| Q4 25 | $-0.28 | $-0.35 | ||
| Q3 25 | $0.01 | $-0.37 | ||
| Q2 25 | $0.01 | $-0.38 | ||
| Q1 25 | $-0.08 | $-0.36 | ||
| Q4 24 | $-0.00 | — | ||
| Q3 24 | $-0.04 | $-1.85 | ||
| Q2 24 | $-0.04 | — | ||
| Q1 24 | $-0.15 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $41.5M | $159.3M |
| 总债务越低越好 | $48.4M | — |
| 股东权益账面价值 | $128.8M | $155.3M |
| 总资产 | $221.7M | $195.8M |
| 负债/权益比越低杠杆越低 | 0.38× | — |
8季度趋势，按日历期对齐
现金及短期投资AXGNCBLL
| Q4 25 | $41.5M | $159.3M | ||
| Q3 25 | $35.8M | $168.5M | ||
| Q2 25 | $29.9M | $177.4M | ||
| Q1 25 | $22.1M | $182.7M | ||
| Q4 24 | $33.5M | — | ||
| Q3 24 | $24.5M | $14.1M | ||
| Q2 24 | $21.1M | — | ||
| Q1 24 | $17.6M | — |
总债务AXGNCBLL
| Q4 25 | $48.4M | — | ||
| Q3 25 | $48.2M | — | ||
| Q2 25 | $47.9M | — | ||
| Q1 25 | $47.7M | — | ||
| Q4 24 | $47.5M | — | ||
| Q3 24 | $47.3M | — | ||
| Q2 24 | $47.0M | — | ||
| Q1 24 | $46.8M | — |
股东权益AXGNCBLL
| Q4 25 | $128.8M | $155.3M | ||
| Q3 25 | $120.8M | $164.1M | ||
| Q2 25 | $112.3M | $172.2M | ||
| Q1 25 | $105.4M | $180.9M | ||
| Q4 24 | $103.9M | — | ||
| Q3 24 | $99.4M | $-136.0M | ||
| Q2 24 | $95.7M | — | ||
| Q1 24 | $93.2M | — |
总资产AXGNCBLL
| Q4 25 | $221.7M | $195.8M | ||
| Q3 25 | $216.4M | $199.5M | ||
| Q2 25 | $205.5M | $207.7M | ||
| Q1 25 | $196.2M | $213.5M | ||
| Q4 24 | $203.7M | — | ||
| Q3 24 | $192.0M | $47.1M | ||
| Q2 24 | $188.9M | — | ||
| Q1 24 | $186.5M | — |
负债/权益比AXGNCBLL
| Q4 25 | 0.38× | — | ||
| Q3 25 | 0.40× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.45× | — | ||
| Q4 24 | 0.46× | — | ||
| Q3 24 | 0.48× | — | ||
| Q2 24 | 0.49× | — | ||
| Q1 24 | 0.50× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.0M | $-10.8M |
| 自由现金流经营现金流 - 资本支出 | $1.8M | $-11.0M |
| 自由现金流率自由现金流/营收 | 3.0% | -44.2% |
| 资本支出强度资本支出/营收 | 2.1% | 0.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-2.9M | $-41.6M |
8季度趋势，按日历期对齐
经营现金流AXGNCBLL
| Q4 25 | $3.0M | $-10.8M | ||
| Q3 25 | $3.2M | $-11.1M | ||
| Q2 25 | $7.7M | $-7.5M | ||
| Q1 25 | $-13.2M | $-11.4M | ||
| Q4 24 | $8.7M | — | ||
| Q3 24 | $3.9M | — | ||
| Q2 24 | $4.2M | — | ||
| Q1 24 | $-12.3M | — |
自由现金流AXGNCBLL
| Q4 25 | $1.8M | $-11.0M | ||
| Q3 25 | $1.7M | $-11.5M | ||
| Q2 25 | $7.0M | $-7.6M | ||
| Q1 25 | $-13.4M | $-11.6M | ||
| Q4 24 | $8.1M | — | ||
| Q3 24 | $3.3M | — | ||
| Q2 24 | $3.3M | — | ||
| Q1 24 | $-13.2M | — |
自由现金流率AXGNCBLL
| Q4 25 | 3.0% | -44.2% | ||
| Q3 25 | 2.8% | -50.8% | ||
| Q2 25 | 12.4% | -35.9% | ||
| Q1 25 | -27.7% | -56.4% | ||
| Q4 24 | 16.3% | — | ||
| Q3 24 | 6.8% | — | ||
| Q2 24 | 6.8% | — | ||
| Q1 24 | -31.9% | — |
资本支出强度AXGNCBLL
| Q4 25 | 2.1% | 0.7% | ||
| Q3 25 | 2.5% | 1.6% | ||
| Q2 25 | 1.3% | 0.3% | ||
| Q1 25 | 0.5% | 0.7% | ||
| Q4 24 | 1.4% | — | ||
| Q3 24 | 1.2% | — | ||
| Q2 24 | 1.9% | — | ||
| Q1 24 | 2.2% | — |
现金转化率AXGNCBLL
| Q4 25 | — | — | ||
| Q3 25 | 4.55× | — | ||
| Q2 25 | 13.35× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 19.41× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXGN
暂无分部数据
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
